GDPR Considerations for DtP Supply Chains
Regulatory, Supply Chain
One of the primary challenges with Direct-to-Patient (DtP) supply chains is maintaining patient privacy. This is further complicated by the GDPR (General Data Protection Regulation), which is broadly designed to protect the right to personal data privacy for all EU citizens. The GCSG DTP Sub-team provides an overview of the key GDPR considerations and recommendations for organizations engaged in DtP.
Related Education Resources.
All ResourcesCurrent Challenges in Cell and Gene Therapy
Topic: Regulatory
Webinar
Free
EU Clinical Trial Regulation 536/2014
Topic: Regulatory
Position Paper
Members
PATIENT Receptivity to Direct-to-Patient Shipment in Clinical Trials - a GCSG sponsored study
Topic: Direct-to-Patient
White Paper
Members
